| Effectiveness of Rifabutin for Treatment of Helicobacter Pylori (NCT04652284) | Rabin Medical Center | 2021-05-01 |
| Association Between Helicobacter Pylori and Inflammatory Bowel Disease (NCT03820284) | Assiut University | 2019-02-01 |
| A Unique Regimen for Treatment of Helicobacter Pylori Infection (NCT03491995) | Sherief Abd-Elsalam | 2018-04-01 |
| A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children (NCT03365609) | Ying HUANG | 2017-09-20 |
| Specimen Collection Study for H. Pylori Testing (NCT02970110) | Biomerica | 2017-02-27 |
| The Effect of Probiotic Combination on Helicobacter Pylori Infection in Children (NCT02645201) | University Medical Centre Ljubljana | 2016-01-01 |
| Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection (NCT02401477) | Il-Yang Pharm. Co., Ltd. | 2014-12-01 |
| Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy (NCT02126722) | Niso Biomed S.R.L. | 2014-06-01 |
| Helicobacter Pylori and Proton Pump Inhibitor (NCT02449941) | Asan Medical Center | 2014-03-01 |
| Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens (NCT02395458) | Coordinación de Investigación en Salud, Mexico | 2013-03-01 |
| A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection (NCT01219764) | American University of Beirut Medical Center | 2010-10-01 |
| Helicobacter Pylori Eradication to Prevent Gastric Cancer (NCT01133951) | Jie-Jun Wang | 2010-06-01 |
| Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients (NCT00723502) | MerLion Pharmaceuticals GmbH | 2008-09-01 |
| Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy (NCT00669955) | Forest Laboratories | 2008-06-01 |
| Treating H. Pylori in Parkinson's Patients With Motor Fluctuations (NCT00664209) | University of California, Los Angeles | 2008-01-01 |
| First Time in Man Study of Finafloxacin Hydrochloride (NCT00483158) | MerLion Pharmaceuticals GmbH | 2007-08-01 |
| Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication (NCT00816140) | National Taiwan University Hospital | 2007-06-01 |
| Helicobacter Pylori and Acute Alcohol Induced Pancreatitis (NCT00490386) | Tampere University | 2006-06-01 |
| Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults. (NCT00216450) | Janssen Cilag Pharmaceutica S.A.C.I., Greece | 2004-10-01 |
| Helicobacter Pylori and Dry Eye (NCT00083291) | National Eye Institute (NEI) | 2004-05-01 |
| Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection (NCT00197418) | Hamamatsu University | 2003-08-01 |
| Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori (NCT00149084) | Hamamatsu University | 2003-04-01 |
| Breath Ammonia Method for H. Pylori Detection: Phase II (NCT00194688) | University of Washington | 2003-03-01 |
| Eradication Rates of Helicobacter Pylori and Its Affecting Factors (NCT01922505) | Seoul National University Bundang Hospital | 2003-01-01 |
| Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy (NCT01792700) | Seoul National University Bundang Hospital | 2003-01-01 |
| Infection and Cardiovascular Disease (NCT00005547) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-04-01 |
| Inflammation, Infection, and Future Cardiovascular Risk (NCT00005496) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-09-01 |
| Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) (NCT00212225) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1997-10-01 |